Whereas the newly developed DHODH inhibitor MEDS433 had limited efficacy in vitro when subjected to physiological concentrations of uridine, combining DHODH inhibition and dipyridamole caused an increase in toxicity and, therefore, cell death in AML cells but not in non-cancer cells. The gene discussed is DHODH; the disease is cancer.